The NDA is supported by clinical studies exploring the use of 12 weeks of SOF/VEL for patients with genotype 1-6 HCV infection, including patients with compensated cirrhosis and
The goal of the co-operation is the supply of the Indonesian patients with cost-effective high quality biopharmaceuticals. Under the terms of the agreement ProBioGen will develop a highly
The company’s latest report states that this growth, which will occur across the 10 major markets of the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and
Under the contract, SRI Biosciences, a division of SRI International, will conduct all research and testing necessary to submit Investigational New Drug (IND) applications for promising drugs and
Arena intends to focus on its key strengths by concentrating near-term activities and resources primarily on: advancing its APD334 program, including the ongoing Phase 2 clinical trial for
According to IMS, for the 12 months ending August 2015, the US market for Chlorothiazide approximated $29m. As with all products in Sagent’s portfolio, Chlorothiazide features Sagent’s PreventIV
The 33,000 square foot facility provides 25 percent more space than PRA’s previous lab, includes investments in the newest small and large molecule equipment, and allows for optimal
The clinical trial application for the varicella vaccine was officially accepted by the China Food and Drug Administration (CFDA) in January 2013. In preparation to begin human clinical
The E.coli|360-HCP ELISA allows sponsors and biotech companies to postpone the development of a cost-intensive specific HCP assay until a more informed decision on the success of a
The systems are synergistic, complementary and work well together. Daylight IQ will now pre-populate select INTERACT forms based on existing nursing documentation. This exchange of data positively impacts
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.